In particular, the vimentin and RACK1 down-regulation in Het animals may represent a potential molecular link between the KD carrier and the risk of developing neuropathies, principally related to mechanosignaling and intracellular trafficking defects as well as to an altered myelin turnover associated with cytoskeleton dysfunctions. The gene discussed is VIM; the disease is neuropathy.